INAB - IN8bio Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-09-11)
Last
 2.09		 Change
 ⇑ +0.15   (+7.73%)		 Volume
  48,391
Open
 1.93		 High
 2.12		 Low
 1.93
8EMA (Daily)
 2.11		 40EMA (Daily)
 2.30		 50EMA (Daily)
 2.41		 STO (Daily)
 21.799		 MACD Hist (Daily)
 -0.023
8EMA (Weekly)
 2.268		 40EMA (Weekly)
 5.81		 50EMA (Weekly)
 7.59		 STO (Weekly)
 10.746		 MACD Hist (Weekly)
 0.594
Company Profile
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com